Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 17, 2026

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
11:07

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: September 5, 2025

Pancreatic surgery: beyond the traditional limits.

Sascha A Müller1, Ignazio Tarantino, David J Martin

  • 1Department of Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|November 7, 2012
PubMed
Summary

Extended pancreatic surgery offers curative potential for selected patients. Portal vein resection is established, while arterial resection is reserved for rare cases. Multivisceral resections are feasible for locally invasive tumors.

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between hospital volume and mortality after elective oesophageal cancer resection in Switzerland: a retrospective national registry study from 2013 to 2022.

Langenbeck's archives of surgery·2026
Same author

Assessing complications following pancreatoduodenectomy: the Comprehensive Complication Index versus the Clavien-Dindo classification.

BJS open·2026
Same author

Oncologic multivisceral resections involving the pancreas.

International journal of surgery (London, England)·2025
Same author

Patterns of infectious complications and their implication on health system costs after esophagectomy for esophageal cancer: Real-world data from three European centers.

Langenbeck's archives of surgery·2025
Same author

Long-term outcomes of the Universal 2 total wrist arthroplasty.

Journal of orthopaedics·2025
Same author

Perioperative blood transfusion does not impair survival after partial pancreaticoduodenectomy for periampullary cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025

Area of Science:

  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic cancer is a leading cause of cancer death globally.
  • While complete surgical resection is key, many patients with resectable tumors do not receive surgery, despite potential for high survival rates.
  • The incidence of cystic pancreatic tumors is increasing.

Purpose of the Study:

  • To evaluate the role and outcomes of extended pancreatic operations beyond standard surgical procedures.
  • To assess the feasibility and impact of major venous and arterial resection, multivisceral resections, and surgery for metastatic pancreatic cancer.

Main Methods:

  • Review of data on extended pancreatic resections, including portal vein resection, arterial resection, multivisceral resection, and palliative resection for metastatic disease.
  • Analysis of perioperative morbidity, mortality, and oncologic outcomes.

Related Experiment Videos

Last Updated: May 17, 2026

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
11:07

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: September 5, 2025

Main Results:

  • Portal vein resection for local infiltration is well-established with acceptable outcomes.
  • Arterial resection is technically feasible but has questionable oncologic benefit and is reserved for specific cases.
  • Multivisceral resections, despite increased morbidity, show comparable survival rates to non-extended resections for locally invasive tumors.
  • Extended lymphadenectomy offers no demonstrated advantage.
  • Routine resection for metastatic disease is generally not advantageous over palliative treatment.

Conclusions:

  • Extended pancreatic surgery, particularly for venous system infiltration, is a viable approach.
  • Multivisceral resections should be considered for technically feasible locally infiltrating pancreatic cancer.
  • Surgery for metastatic pancreatic cancer may be an option in highly selected patients.